Swedish Health

Seattle, Washington 98122

1 studies enrolling now · 2 studies all time

What they study most

CLL/SLL, LAM, Lymphangioleiomyomatosis

Studies at this site

• Study of APG-2575 as a Single Agent or in Combination With Other Therapeutic Agents for CLL/SLL — Recruiting now
• Multicenter Interventional Lymphangioleiomyomatosis (LAM) Early Disease Trial — Running, not enrolling